Trials / Terminated
TerminatedNCT00665730
Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions
Evaluation of the Safety and Effectiveness of Sepraspray™ in Limiting the Formation of Postoperative Adhesions to Serosal Tissue (Abdominal Surgery)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Genzyme, a Sanofi Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the safety and efficacy of Sepraspray in the following model of abdominal surgery: total proctocolectomy and pelvic pouch with diverting ileostomy via laparotomy to treat ulcerative colitis or familial polyposis. Adhesion formation will be evaluated laparoscopically at ileostomy take down. NOTE: A decision was made to terminate this study in June 2008 due to low enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sepraspray |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-04-24
- Last updated
- 2015-05-08
Locations
6 sites across 5 countries: Czechia, Denmark, France, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT00665730. Inclusion in this directory is not an endorsement.